skip to main content 
Clinical Trials & Research Opportunities
Since 2008, nearly 8,000 men and women have participated in over a dozen RMA clinical trials aimed at improving patient outcomes.
Our Research Program
Over the years, RMA has given away more than 1,000 IVF cycles and more than 780 embryo screenings at no cost as part of its research program. This is an investment we make to improve patient outcomes and continue to set evidence-based standards in reproductive medicine. Below you will find a list of our current research opportunities and past study opportunities our patients have been involved with.
Clinical Trials & Research Opportunities
Platelet Rich Plasma for Insufficient Endometrium: a Randomized Controlled Trial
Have you been diagnosed with thin uterine lining?
See if you are eligible for the PIER study which is trying to determine whether a uterine infusion of Platelet Rich Plasma (PRP) helps to thicken the uterine lining in participants who have a history of thin uterine lining.
What is PRP?
PRP is generated from the participant’s own blood containing platelets and other growth factors. PRP is thought to expedite healing and tissue recovery. Since it’s made from the participant’s own blood, it is thought to be well received by the body.
What is the study?
This is a prospective, double-blind, placebo-controlled, randomized controlled trial which is the gold standard for determining treatment effectiveness. This means that participants will be randomly assigned, like the flip of a coin, to either receive the PRP infusion (intervention group) or a mock infusion of normal saline (control group). This is how the researchers will determine if the PRP is beneficial by comparing it to an inactive or placebo infusion. Additionally, neither the participant nor the primary care team will be aware of which infusion the participant received until after the pregnancy test has resulted.
Who can participate?
You may not be eligible if you have had abnormal development of your uterus, a present uterine defect that requires surgical intervention, require blood thinners during treatment or have a history of or are at an increased risk of blood clots.
Contact Us
Clinical Research Team | [email protected] | 973-656-2841